Preliminary results from the first-in-child phase II trial (ITCC-054/COG-AAML1921) of bosutinib in pediatric patients with newly diagnosed (ND) chronic myeloid leukemia (CML).

Authors :: Pennesi, Edoardo
Brivio, Erica
Willemse, Marieke E
Jiang, Yilin
van der Velden, Vincent HJ
Beverloo, H Berna
Hudson, Chad
Heerema, Nyla A
Kuttschreuter, Luke
Frediani, Jamie
Spiller, Susan
Batra, Sandeep
Redell, Michele
Bertorello, Nicoletta
Locatelli, Franco
van der Sluis, Inge M
Roth, Michael
Hijiya, Nobuko
Zwaan, C Michel
Source :: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p10017-10017, 1p
Publication Year :: 2023

Full Text Access

Tools